Market cap
₹2,435 Cr
Revenue (TTM)
₹503 Cr
P/E Ratio
36.2
P/B Ratio
7.4
Div. Yield
0 %
Quality Score
4/10
Growth Score
8/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹67 Cr
-
ROE
16.4 %
-
ROCE
18.4 %
-
Industry P/E
34.33
-
EV/EBITDA
21.2
-
Debt to Equity
0.1
-
Book Value
₹318.8
-
EPS
₹65.5
-
Face value
10
-
Shares outstanding
10,376,198
10 Years Aggregate
CFO
₹245.01 Cr
EBITDA
₹463.40 Cr
Net Profit
₹242.27 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kwality Pharma
| -- | 36.3 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 9.3 | 0.6 | 11.8 | 9.5 | 23.7 | 13.8 | 12.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kwality Pharma
|
2,342.6 | 2,434.8 | 503.1 | 67.3 | 19.6 | 21.9 | 36.2 | 7.4 |
| 3,073.6 | 38,417.1 | 5,452.9 | 1,056.0 | 22.4 | 25.4 | 36.4 | 8.5 | |
| 8,529.0 | 21,286.3 | 2,275.6 | 187.5 | 10.3 | 22.9 | 113.5 | 24.4 | |
| 2,359.4 | 17,934.6 | 2,187.2 | 649.7 | 31.5 | 19 | 28 | 5.0 | |
| 1,836.0 | 11,208.5 | 1,403.2 | 185.1 | -- | 27.4 | 60.5 | 15.0 | |
| 1,430.6 | 19,822.7 | 3,129.4 | 647.4 | 26.9 | 18.1 | 32 | 5.1 | |
| 2,198.5 | 35,304.5 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.8 | 8.5 | |
| 4,539.3 | 20,766.7 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.7 | 4.9 | |
| 6,310.5 | 10,485.7 | 1,408.0 | 326.9 | 30.8 | 57.1 | 32.1 | 20.0 | |
| 545.6 | 10,673.9 | 1,538.1 | 226.2 | 20.4 | 9 | 43.9 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Kwality Pharma
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
1983
-
Chairman
--
-
Managing Director
Ramesh Kumar
-
Headquarters
Amritsar, Punjab
-
Website
Looking for more details about Kwality Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Quarterly Updates
Annual Reports
FAQs for Kwality Pharma
What is the current share price of Kwality Pharmaceuticals Ltd Today?
The share price of Kwality Pharmaceuticals Ltd is ₹2,342.60 (NSE) and ₹2,346.55 (BSE) as of 18-Jun-2026 IST. Kwality Pharmaceuticals Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Kwality Pharmaceuticals Ltd?
The P/E ratio of Kwality Pharmaceuticals Ltd is 36.15 times as on 18-Jun-2026, a 5 premium to its peers’ median range of 34.33 times.
The P/B ratio of Kwality Pharmaceuticals Ltd is 7.36 times as on 18-Jun-2026, a 51 premium to its peers’ median range of 4.86 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
22.63
|
3.43
|
|
2024
|
17.85
|
1.90
|
|
2023
|
16.47
|
1.60
|
|
2022
|
5.02
|
3.34
|
|
2021
|
3.84
|
0.96
|
What is the 52 Week High and Low of Kwality Pharmaceuticals Ltd?
The 52-week high and low of Kwality Pharmaceuticals Ltd are Rs 2,600.00 and Rs 1,561.00 as of 19-Jun-2026.
What is the market cap of Kwality Pharmaceuticals Ltd?
Kwality Pharmaceuticals Ltd has a market capitalisation of ₹ 2,435 Cr as on 18-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Kwality Pharmaceuticals Ltd?
Before investing in Kwality Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.